Premium
Primary cutaneous mucormycosis in a lung transplant recipient: case report and concise review of the literature
Author(s) -
Page A.V.,
Evans A.J.,
Snell L.,
Liles W.C.
Publication year - 2008
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/j.1399-3062.2008.00324.x
Subject(s) - mucormycosis , zygomycosis , medicine , lung , solid organ , incidence (geometry) , organ transplantation , hematopoietic stem cell transplantation , dermatology , transplantation , disease , pathology , surgery , amphotericin b , antifungal , physics , optics
Mucormycosis (zygomycosis) is an invasive, opportunistic fungal infection caused by organisms of the class Zygomycetes. Immunocompromised individuals, including both solid organ and hematopoietic stem cell transplant recipients, are preferentially affected. Among solid organ transplant (SOT) recipients, the sinuses, with or without involvement of the orbits and cerebrum, are the most common sites of disease, although the pulmonary allograft appears to be targeted following lung transplantation. Here, we describe the unique case of a lung transplant recipient who developed multifocal cutaneous mucormycosis without involvement of the pulmonary allograft, and review the published literature regarding incidence, treatment, and prognosis of primary cutaneous mucormycosis following SOT.